Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
The second-largest cause of X-linked mental retardation is a deficiency in creatine transporter (CRT; encoded by SLC6A8), which leads to speech and language disorders with severe cognitive impairment. This syndrome, caused by the absence of creatine in the brain, is currently untreatable because CRT is required for creatine entry into brain cells. Here, we developed a brain-specific Slc6a8 knockout mouse (Slc6a8-/y) as an animal model of human CRT deficiency in order to explore potential therapies for this syndrome. The phenotype of the Slc6a8-/y mouse was comparable to that of human patients. We successfully treated the Slc6a8-/y mice with the creatine analog cyclocreatine. Brain cyclocreatine and cyclocreatine phosphate were detected after 9 weeks of cyclocreatine treatment in Slc6a8-/y mice, in contrast to the same mice treated with creatine or placebo. Cyclocreatine-treated Slc6a8-/y mice also exhibited a profound improvement in cognitive abilities, as seen with novel object recognition as well as spatial learning and memory tests. Thus, cyclocreatine appears promising as a potential therapy for CRT deficiency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Desired intake of cyclocreatine was approximately 0.28 mg/g of body weight/day, which is approximately the same as the standard creatine dose used in humans of 285 mg/kg of body weight/day (Kurosawa et al., 2012).”
From TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease (2017) · cites this paper as Kurosawa et al., 2012
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950 · cited 3×
“Creatine and its phosphorylated form, phosphocreatine, are used as an energy reservoir by buffering ATP concentration via the creatine kinase (CK) reaction (1).”
Inducible Gene Targeting in Mice Using the Cre/loxSystem
Sauer, B. (1998) · Methods · doi:10.1006/meth.1998.0593 · Cited by 762
Park, H. R., Park, M., Choi, J., Park, K.-Y., Chung, H. Y., & Lee, J. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.07.046 · Cited by 374
Dietary ketosis enhances memory in mild cognitive impairment
Krikorian, R., Shidler, M. D., Dangelo, K., Couch, S. C., Benoit, S. C., & Clegg, D. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.006 · Cited by 361
Self-citationInborn Metabolic Diseases: Diagnosis and Treatment
(2006) · Springer eBooks · doi:10.1007/978-3-540-28785-8 · Cited by 361
A CamKIIα iCre BAC allows brain‐specific gene inactivation
Casanova, E., Fehsenfeld, S., Mantamadiotis, T., Lemberger, T., Greiner, E., Stewart, A. F., & Schütz, G. (2001) · genesis · doi:10.1002/gene.1078 · Cited by 292
Rae, C., Digney, A. L., McEwan, S. R., & Bates, T. C. (2003) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.2003.2492 · Cited by 283
Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis
Taicher, G. Z., Tinsley, F. C., Reiderman, A., & Heiman, M. L. (2003) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-003-2224-3 · Cited by 256
Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study
Braissant, O., Henry, H., Loup, M., Eilers, B., & Bachmann, C. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00269-2 · Cited by 232
Conn, P. M. (2003) · Humana Press eBooks · doi:10.1385/1592593712 · Cited by 224
High Prevalence of SLC6A8 Deficiency in X-Linked Mental Retardation
Rosenberg, E. H., Almeida, L. S., Kleefstra, T., deGrauw, R. S., Yntema, H. G., Bahi, N., Moraine, C., Ropers, H.-H., Fryns, J.-P., deGrauw, T. J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/422102 · Cited by 213
Self-citationOhtsuki, S., Tachikawa, M., Takanaga, H., Shimizu, H., Watanabe, M., Hosoya, K.-I., & Terasaki, T. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200211000-00006 · Cited by 196
Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation
Watanabe, A., Kato, N., & Kato, T. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00007-x · Cited by 196
Creatine and the creatine transporter: A review
Snow, R. J., & Murphy, R. M. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1011908606819 · Cited by 192
Cecil, K. M., Salomons, G. S., Ball, W. S., Wong, B., Chuck, G., Verhoeven, N. M., Jakobs, C., & DeGrauw, T. J. (2001) · Annals of Neurology · doi:10.1002/ana.79 · Cited by 181
Self-citationTachikawa, M., Fukaya, M., Terasaki, T., Ohtsuki, S., & Watanabe, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03478.x · Cited by 173
Schulze, A., Hess, T., Wevers, R., Mayatepek, E., Bachert, P., Marescau, B., Knopp, M. V., De Deyn, P. P., Bremer, H. J., & Rating, D. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70075-1 · Cited by 170
GAMT deficiency: Features, treatment, and outcome in an inborn error of creatine synthesis
Mercimek-Mahmutoglu, S., Stoeckler-Ipsiroglu, S., Adami, A., Appleton, R., Araújo, H. C., Duran, M., Ensenauer, R., Fernandez-Alvarez, E., Garcia, P., Grolik, C., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000234852.43688.bf · Cited by 158
Walsh, B., Tonkonogi, M., Soderlund, K., Hultman, E., Saks, V., & Sahlin, K. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00971.x · Cited by 155
Reversible brain creatine deficiency in two sisters with normal blood creatine level
Bianchi, M. C., Tosetti, M., Fornai, F., Grazia Alessandri', M., Cipriani, P., De Vito, G., & Canapicchi, R. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<511::aid-ana15>3.0.co;2-n · Cited by 148
Almeida, L. S., Verhoeven‐Duif, N. M., Roos, B., Valongo, C., Cardoso, M. L., Vilarinho, L., Salomons, G. S., & Jakobs, C. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.05.001 · Cited by 137
Specificity of creatine kinase. New glycocyamines and glycocyamine analogs related to creatine
Rowley, G. L., Greenleaf, A. L., & Kenyon, G. L. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00750a038 · Cited by 131
Braissant, O., Henry, H., Villard, A.-M., Speer, O., Wallimann, T., & Bachmann, C. (2005) · BMC Developmental Biology · doi:10.1186/1471-213x-5-9 · Cited by 125
Creatine Transporter (CrT; Slc6a8) Knockout Mice as a Model of Human CrT Deficiency
Skelton, M. R., Schaefer, T. L., Graham, D. L., deGrauw, T. J., Clark, J. F., Williams, M. T., & Vorhees, C. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016187 · Cited by 124
Self-citationWalsh, B., Tonkonogi, M., Soderlund, K., Hultman, E., Saks, V, & Sahlin, K. (2001) · The Journal of Physiology · doi:10.1113/jphysiol.2001.012858 · Cited by 122
Bürklen, T. S., Schlattner, U., Homayouni, R., Gough, K., Rak, M., Szeghalmi, A., & Wallimann, T. (2006) · BioMed Research International · doi:10.1155/jbb/2006/35936 · Cited by 116
Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers
Braissant, O. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9433-2 · Cited by 112 · cited 1×
“Slc6a8 –/y mice had a phenotype with markedly reduced levels of creatine in the brain, similar to what is seen in human patients (37), as well as impaired cognitive function, normal motor function, and normal creatine levels in skeletal muscles, heart, and serum.”
Battini, R., Leuzzi, V., Carducci, C., Tosetti, M., Bianchi, M. C., Item, C. B., Stöckler‐Ipsiroglu, S., & Cioni, G. (2002) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00175-0 · Cited by 105
Dissociation of AGAT, GAMT and SLC6A8 in CNS: Relevance to creatine deficiency syndromes
Braissant, O., Béard, E., Torrent, C., & Henry, H. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.022 · Cited by 94 · cited 2×
“Some previous studies suggest that the rodent brain has the enzymes to synthesize creatine (4, 5, 26, 27).”
Stadhouders, A. M., Jap, P. H., Winkler, H. P., Eppenberger, H. M., & Wallimann, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.5089 · Cited by 94
Functional Insights into the Creatine Transporter
Christie, D. L. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6486-9_6 · Cited by 89
X‐linked creatine deficiency syndrome: A novel mutation in creatine transporter gene SLC6A8
Bizzi, A., Bugiani, M., Salomons, G. S., Hunneman, D. H., Moroni, I., Estienne, M., Danesi, U., Jakobs, C., & Uziel, G. (2002) · Annals of Neurology · doi:10.1002/ana.10246 · Cited by 88
The clinical syndrome of creatine transporter deficiency
de Grauw, T. J., Cecil, K. M., Byars, A. W., Salomons, G. S., Ball, W. S., & Jakobs, C. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1022487218904 · Cited by 85
The clinical syndrome of creatine transporter deficiency
deGrauw, T. J., Cecil, K. M., Byars, A. W., Salomons, G. S., Ball, W. S., & Jakobs, C. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0247-0_6 · Cited by 84
Self-citationFink, G. R., Driver, J., Rorden, C., Baldeweg, T., & Dolan, R. J. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<440::aid-ana6>3.0.co;2-e · Cited by 82
Arias, Á., Corbella, M., Fons, C., Sempere, Á., García‐Villoria, J., Ormazábal, A., Póo, P., Pineda, M., Vilaseca, M. A., Campistol, J., et al. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.07.010 · Cited by 75
Creatine and Creatine Kinase in Health and Disease
Salomons, G. S., & Wyss, M. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-6486-9 · Cited by 75
X‐Linked creatine transporter deficiency in two patients with severe mental retardation and autism
Póo‐Argüelles, P., Arias, A., Vilaseca, M. A., Ribes, A., Artuch, R., Sans‐Fito, A., Moreno, A., Jakobs, C., & Salomons, G. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0212-4 · Cited by 74
Ensenauer, R., Thiel, T., Schwab, K. O., Tacke, U., Stöckler-Ipsiroglu, S., Schulze, A., Hennig, J., & Lehnert, W. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.04.005 · Cited by 71 · cited 1×
“…have been successfully treated with creatine supplementation, which reverses symptoms, as well as other supplements, which manage buildup of intermediate metabolites (13–15, 21, 22); however, patients with CRT deficiency are not successfully treated with creatine supplementation (10, 16, 23–25).”
The utilisation of creatine and its analogues by cytosolic and mitochondrial creatine kinase
Boehm, E. A., Radda, G. K., Tomlin, H., & Clark, J. F. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00018-7 · Cited by 69
Self-citationLaboratory diagnosis of defects of creatine biosynthesis and transport
Verhoeven‐Duif, N. M., Salomons, G. S., & Jakobs, C. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.04.022 · Cited by 68
Specificity of Creatine Kinase for Guanidino Substrates
McLaughlin, A. C., Cohn, M., & Kenyon, G. L. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45084-9 · Cited by 64
Fluorimetric Determination of Creatine
Conn, R. B. (1960) · Clinical Chemistry · doi:10.1093/clinchem/6.6.537 · Cited by 64
NEWMEYER, A., CECIL, K. M., SCHAPIRO, M., CLARK, J. F., & DEGRAUW, T. J. (2005) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200508000-00003 · Cited by 63
Self-citationIreland, Z., Russell, A. P., Wallimann, T., Walker, D. W., & Snow, R. (2009) · BMC Developmental Biology · doi:10.1186/1471-213x-9-39 · Cited by 63
Tachikawa, M., Fujinawa, J., Takahashi, M., Kasai, Y., Fukaya, M., Sakai, K., Yamazaki, M., Tomi, M., Watanabe, M., Sakimura, K., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05652.x · Cited by 59
Mancini, G. M. S., Catsman‐Berrevoets, C. E., de Coo, I. F. M., Aarsen, F. K., Kamphoven, J. H. J., Huijmans, J. G., Duran, M., van der Knaap, M. S., Jakobs, C., & Salomons, G. S. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30473 · Cited by 56
Arginine supplementation in four patients with X‐linked creatine transporter defect
Fons, C., Sempere, A., Arias, A., López‐Sala, A., Póo, P., Pineda, M., Mas, A., Vilaseca, M. A., Salomons, G. S., Ribes, A., et al. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0902-1 · Cited by 53
The screening of SLC6A8 deficiency among Estonian families with X‐linked mental retardation
Puusepp, H., Kall, K., Salomons, G. S., Talvik, I., Männamaa, M., Rein, R., Jakobs, C., & Õunap, K. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-1063-y · Cited by 52
Chilosi, A., Leuzzi, V., Battini, R., Tosetti, M., Ferretti, G., Comparini, A., Casarano, M., Moretti, E., Alessandrì, M. G., Bianchi, M. C., et al. (2008) · Neurocase · doi:10.1080/13554790802060821 · Cited by 49
Griffiths, G. R., & Walker, J. B. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33653-0 · Cited by 44
Stöckler-Ipsiroglou, S., Mercimek‐Andrews, S., & Salomons, G. S. (2016) · Springer eBooks · doi:10.1007/978-3-662-49771-5_15 · Cited by 44
Woznicki, D. T., & Walker, J. B. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb09966.x · Cited by 42
Pyne‐Geithman, G. J., deGrauw, T. J., Cecil, K. M., Chuck, G., Lyons, M. A., Ishida, Y., & Clark, J. F. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000038213.15646.4a · Cited by 36
Self-citationCyclocreatine in cancer chemotherapy
Teicher, B. A., Menon, K., Northey, D., Liu, J., Kufe, D. W., & Kaddurah‐Daouk, R. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050255 · Cited by 33
Annesley, T. M., & Walker, J. B. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34370-3 · Cited by 32
Woznicki, D. T., & Walker, J. B. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb11708.x · Cited by 24
LoPresti, P., & Cohn, M. (1989) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(89)90291-4 · Cited by 23
Stöckler‐Ipsiroglu, S., & Salomons, G. S. (2006) · Springer eBooks · doi:10.1007/978-3-540-28785-8_16 · Cited by 22
Creatine transporter deficiency in two adult patients with static encephalopathy
Sempere, A., Fons, C., Arias, Á., Rodríguez‐Pombo, P., Colomer, R., Merinero, B., Alcaide, P., Capdevila, A., Ribes, A., Artuch, R., et al. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1083-2 · Cited by 17
Screening of Male Patients with Autism Spectrum Disorder for Creatine Transporter Deficiency
Newmeyer, A., deGrauw, T., Clark, J., Chuck, G., & Salomons, G. (2007) · Neuropediatrics · doi:10.1055/s-2008-1065353 · Cited by 16
Self-citationAntiproliferative effects of cyclocreatine on human prostatic carcinoma cells.
Hoosein, N. M., Martin, K. J., Abdul, M., Logothetis, C. J., & Kaddurah-Daouk, R. F. (1995) · PubMed · Cited by 15
Ion Channels, Transporters, and Electrical Signaling
Stojilković, S. S. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-455-5_3 · Cited by 7
Research works printed but not linked: 1
- Hoosein, 1995, Anticancer Res., 15, 1339
Cited by
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
Ulland, T. K., Song, W. M., Huang, S. C.-C., Ulrich, J. D., Sergushichev, A., Beatty, W. L., Loboda, A. A., Zhou, Y., Cairns, N. J., Kambal, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.023 · Cited by 1,263
SLC Transporters as Therapeutic Targets: Emerging Opportunities
Lin, L., Yee, S. W., Kim, R. B., & Giacomini, K. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4626 · Cited by 835
Rae, C. D. (2014) · Neurochemical Research · doi:10.1007/s11064-013-1199-5 · Cited by 496
Ji, L., Zhao, X., Zhang, B., Kang, L., Song, W., Zhao, B., Xie, W., Chen, L., & Hu, X. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.007 · Cited by 240
Creatine biosynthesis and transport in health and disease
Joncquel-Chevalier Curt, M., Voicu, P.-M., Fontaine, M., Dessein, A.-F., Porchet, N., Mention-Mulliez, K., Dobbelaere, D., Soto-Ares, G., Cheillan, D., & Vamecq, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.10.022 · Cited by 238
Metadata
- Authors
- Kurosawa, Y., DeGrauw, T. J., Lindquist, D. M., Blanco, V. M., Pyne-Geithman, G. J., Daikoku, T., Chambers, J. B., Benoit, S. C., & Clark, J. F.
- Affiliations
- University of Cincinnati (US)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Clark, Joseph F.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-08-01
- Volume
- 122
- Issue
- 8
- Pages
- 2837-2846
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3408730
- OpenAlex
- W2082741813
- Cited by
- 98
- References
- 62
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 11 · 2022: 3 · 2021: 14 · 2020: 8 · 2019: 8 · 2018: 4 · 2017: 6 · 2016: 8 · 2015: 5 · 2014: 10 · 2013: 10 · 2012: 2
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cincinnati Children's Hospital Medical Center
- Tokyo Medical and Dental University
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS049172, NS049172)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- creatine transporter deficiency, SLC6A8, cyclocreatine, X-linked intellectual disability, cognitive impairment, novel object recognition, spatial learning and memory
- MeSH terms
- Animals, Base Sequence, Brain, Cognition, Cognition Disorders, Creatinine, Disease Models, Animal, Female, Humans, Learning, Male, Memory, Mice, Inbred C57BL, Models, Neurological, Phosphocreatine, DNA Primers, Mice, Knockout, Membrane Transport Proteins, Mental Retardation, X-Linked, X-Linked Intellectual Disability, Imidazolidines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.